Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 2
2006 1
2007 3
2008 4
2011 1
2012 2
2013 1
2014 5
2015 2
2016 5
2018 3
2019 5
2020 4
2021 4
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.
Bancet A, Frem R, Jeanneret F, Mularoni A, Bazelle P, Roelants C, Delcros JG, Guichou JF, Pillet C, Coste I, Renno T, Battail C, Cochet C, Lomberget T, Filhol O, Krimm I. Bancet A, et al. Among authors: guichou jf. iScience. 2024 Jan 12;27(2):108903. doi: 10.1016/j.isci.2024.108903. eCollection 2024 Feb 16. iScience. 2024. PMID: 38318383 Free PMC article.
Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration.
Fnaiche A, Chan HC, Paquin A, González Suárez N, Vu V, Li F, Allali-Hassani A, Cao MA, Szewczyk MM, Bolotokova A, Allemand F, Gelin M, Barsyte-Lovejoy D, Santhakumar V, Vedadi M, Guichou JF, Annabi B, Gagnon A. Fnaiche A, et al. Among authors: guichou jf. ACS Med Chem Lett. 2023 Nov 30;14(12):1746-1753. doi: 10.1021/acsmedchemlett.3c00386. eCollection 2023 Dec 14. ACS Med Chem Lett. 2023. PMID: 38116405
Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings.
Fnaiche A, Mélin L, Suárez NG, Paquin A, Vu V, Li F, Allali-Hassani A, Bolotokova A, Allemand F, Gelin M, Cotelle P, Woo S, LaPlante SR, Barsyte-Lovejoy D, Santhakumar V, Vedadi M, Guichou JF, Annabi B, Gagnon A. Fnaiche A, et al. Among authors: guichou jf. Bioorg Med Chem Lett. 2023 Oct 15;95:129488. doi: 10.1016/j.bmcl.2023.129488. Epub 2023 Sep 27. Bioorg Med Chem Lett. 2023. PMID: 37770003
Linkers in fragment-based drug design: an overview of the literature.
Grenier D, Audebert S, Preto J, Guichou JF, Krimm I. Grenier D, et al. Among authors: guichou jf. Expert Opin Drug Discov. 2023 Jul-Dec;18(9):987-1009. doi: 10.1080/17460441.2023.2234285. Epub 2023 Jul 19. Expert Opin Drug Discov. 2023. PMID: 37466331 Review.
A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity.
Schatz M, Marty L, Ounadjela C, Tong PBV, Cardace I, Mettling C, Milhiet PE, Costa L, Godefroy C, Pugnière M, Guichou JF, Mesnard JM, Blaise M, Beaumelle B. Schatz M, et al. Among authors: guichou jf. J Virol. 2023 Apr 27;97(4):e0027823. doi: 10.1128/jvi.00278-23. Epub 2023 Apr 11. J Virol. 2023. PMID: 37129415 Free PMC article.
Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity.
Van Bael J, Vandenbulcke A, Ahmed-Belkacem A, Guichou JF, Pawlotsky JM, Samyn J, Barendrecht AD, Maas C, De Meyer SF, Vanhoorelbeke K, Tersteeg C. Van Bael J, et al. Among authors: guichou jf. Int J Mol Sci. 2023 Apr 12;24(8):7163. doi: 10.3390/ijms24087163. Int J Mol Sci. 2023. PMID: 37108326 Free PMC article.
Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs.
Liberelle M, Toulotte F, Renault N, Gelin M, Allemand F, Melnyk P, Guichou JF, Cotelle P. Liberelle M, et al. Among authors: guichou jf. J Med Chem. 2022 Apr 28;65(8):5926-5940. doi: 10.1021/acs.jmedchem.2c00075. Epub 2022 Apr 7. J Med Chem. 2022. PMID: 35389210 Review.
50 results